Gland Pharmas aktie nådde en ny 52-veckorshögsta efter att bolaget rapporterat starka resultat för marskvartalet och helåret. Den europeiska enheten Cenexi visade tecken på återhämtning, medan nya produktlanseringar och kapacitetsökningar stärkte utsikterna.
Gland Pharmas aktie klättrade till sin högsta nivå på ett år efter publiceringen av starka kvartals- och helårssiffror. Bolaget lyfte fram förbättrad lönsamhet i det europeiska dotterbolaget Cenexi som en viktig positiv faktor.
Laurus Labs reported strong financial results for fiscal 2026, driving a 30 percent gain in its share price. Growth in contract manufacturing and a better product mix supported the performance.
Rapporterad av AI
Sun Pharmaceutical Industries posted robust revenue and profit increases for the March quarter. The company noted pressure on EBITDA margins due to higher investments and reduced milestone income. Outlook for the next fiscal year points to steady but moderated expansion.
European stocks closed the week lower on Friday, with the STOXX 600 index hitting a two-week low. Investors cited concerns over growth and inflation from the ongoing Middle East conflict disrupting energy supplies. While technology shares gained, healthcare and financial sectors declined.
Rapporterad av AI
Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.